Melior Discovery | Company History

• Founded by Dr. Andrew Reaume and Dr. Mike Saporito: January 2005
• $500,000 seed funding from BioAdvance: February 2005
• theraTRACE^SM platform established; 5,000-square-foot facility fully operational: June 2005
• Identified 2 drug candidates for internal development (diabetes & incontinence); "novel method of use" patents filed: September 2005
• Close of $4 million Series A financing: January 2006
• Dr. Jeff Handler joins as Vice President of Development: May 2006
• Additional internal drug candidate identified (dermatitis): June 2006
• Moved into customized 8,000 ft facility in Exton, PA: July 2006